TABP EIC

Allife Medical Science and Technology Co., Ltd. · Phase 1 active Small molecule

At a glance

Generic name	TABP EIC
Sponsor	Allife Medical Science and Technology Co., Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer (EARLY_PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

TABP EIC CI brief — competitive landscape report
TABP EIC updates RSS · CI watch RSS
Allife Medical Science and Technology Co., Ltd. portfolio CI